Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

KPRXKPRX
8 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in KIORA PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 116,011 shares of KPRX (KIORA PHARMACEUTICALS INC), worth $305,109 as of 2026-Q2. The position was increased (+134.2% shares).

Current Value

$305,109

Current Shares

116,011

Total Value Change

+$268,092

Total Shares Change

+105,897

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
116,011
+134.2%
$305,1090.0%$2.63
26
2026-Q1
Increased
49,533
+121.3%
$95,5990.0%$2.02
24
2025-Q4
Decreased
22,381
-49.8%
$44,0910.0%$1.94
0
2025-Q3
New
44,573
-
$124,8040.0%$2.63
34
2025-Q2
Exited
0
-100.0%
$00.0%$2.90
0
2025-Q1
New
26,550
-
$79,9160.0%$3.08
33
2024-Q4
Exited
0
-100.0%
$00.0%$3.30
0
2024-Q3
New
10,114
-
$37,0170.0%$3.43
31

Other major holders of KPRX: Alyeska Investment Group, L.P., TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used